Dermatophytic Onychomycosis Treatment Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET
ANALYSIS

• Dermatophytic Onychomycosis Treatment Market, By
  Product Type (Tablets(Rx, OTC)Mail Paints(Rx,
  OTC)), By Treatment (Oral, Topical), By End User
  (Hospitals, Clinics, Independent Pharmacies, Mail
  Order Pharmacies, Drug Stores), and by Regions
  (North America, Latin America, Europe, Asia
  Pacific, Middle East and Africa) - Size, Share,
  Outlook, and Opportunity Analysis, 2019 - 2027
• The global dermatophytic onychomycosis treatment
  market is estimated to account for US 7,851.4 Mn
  in terms of value by the end of 2027.

3
Global Dermatophytic Onychomycosis Treatment
Market Drivers

• Increasing prevalence of dermatophytic
  onychomycosis is a major factor boosting growth
  of the global Dermatophytic Onychomycosis
  Treatment Market over the forecast period. For
  instance, the study, Dermatophytosis Prevalence
  of Dermatophytes and Non-Dermatophyte Fungi from
  Patients Attending Arsho Advanced Medical
  Laboratory, Addis Ababa, Ethiopia published in
  the journal Dermatology Research and Practice in
  October 2018, demonstrated that the prevalence of
  dermatophytosis was 66.98 in Ethiopia.
• Moreover, increasing prevalence of psoriasis is
  also expected to boost the market growth. For
  instance, the study, The prevalence and
  etiological factors of onychomycosis in psoriatic
  patients, published in the journal Advances in
  Dermatology and Allergology in April 2018,
  demonstrated a relatively high prevalence of
  onychomycosis in patients with psoriasis.

4
Statistics

• North America region held dominant position in
  the global dermatophytic onychomycosis treatment
  market in 2018, accounting for 45.8 share in
  terms of value followed by 2027.

Figure 1. Global Dermatophytic Onychomycosis
Treatment Market Value (US Mn), by Region, 2018
5
Market Restraints

• Antifungal drugs used in the treatment of
  dermatophytic onychomycosis have certain side
  effects such as headache, dizziness, nausea, and
  stomach ache. Moreover, the topical agents also
  cause rash and itchiness in the surrounding skin.
  These side effects are expected to hamper growth
  of the global dermatophytic onychomycosis
  treatment market.
• Moreover, availability of alternative treatment
  options such as Vicks Vapour Listerine and tea
  tree oil for the treatment of nail infections is
  also expected to hinder the market growth.

6
Global Dermatophytic Onychomycosis Treatment
Market Opportunities

• The identification of the infectious agent in
  onychomycosis, at least at the genus level, plays
  major role in the treatment prescription for
  dermatophytic onychomycosis. Key players in the
  market can focus on development of dermatophyte
  strip tests for rapid detection and diagnosis of
  the disease.
• Increasing geriatric population is also expected
  to offer lucrative growth opportunities for
  players in the global dermatophytic onychomycosis
  treatment market. Toenail onychomycosis is common
  in people aged 60 and above. According to the
  World Health Organization, the proportion of the
  world's population over 60 years was 12 in 2015
  and is expected to reach 22 in 2050.

7

• Nail Paints segment in the global dermatophytic
  onychomycosis treatment market was valued at US
  2,713.0 Mn in 2018 and is expected to reach US
  6,086.0 Mn by 2027 at a CAGR of 9.5 during the
  forecast period.

8
Market Trends/Key Takeaways

• The market is witnessing increasing MA
  activities. For instance, in January 2018, Viamet
  Pharmaceuticals entered into an agreement with
  NovaQuest Capital Management, L.L.C. for the
  acquisition of Viamet Pharmaceuticals.
• Key players in the market are focused on
  conducting clinical trials in order to expand
  their product portfolio. For instance, in January
  2018, Novan announced to present the Phase II
  efficacy and safety data for SB208, a topical,
  silicone-based gel under development for the
  treatment of fungal infections of the skin and
  nails at the Winter Clinical Dermatology
  Conference.

9
Global Dermatophytic Onychomycosis Treatment
Market Competitive Landscape

• Major players operating in the global
  dermatophytic onychomycosis treatment market
  include, Valeant Pharmaceuticals International
  Inc., Galderma S.A., Novartis AG, Pfizer Inc.,
  Moberg Pharma AB, Janssen Global Services, LLC
  (Johnson Johnson Services, Inc.), Anacor
  Pharmaceuticals, Inc., NovaQuest Capital
  Management, L.L.C., and Novan, Inc.

10
Key Developments

• Key players in the market are focused on
  conducting clinical trials in order to expand
  their product portfolio. For instance, in
  December 2019, Moberg Pharma AB announced that
  MOB-015 (topical terbinafine) met both primary
  and key secondary endpoints of the clinical Phase
  3 study that assessed the efficacy and safety of
  MOB-015 in patients with mild to moderate distal
  subungual onychomycosis.
• Key players in the market are also focused on
  acquiring distribution rights of products to
  enhance their market share. For instance, in
  September 2018, Cipher Pharmaceuticals Inc.
  acquired the exclusive rights to commercialize,
  promote, sell, and distribute MOB-015 from Moberg
  Pharma in Canada for treatment of onychomycosis.

11

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/dermatophytic-onychomycosis-treatm
  ent-market-2053

12
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

13
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

14

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/